A Prospective, obServational pOst maRketing survEillance study to evAluate the effectiveness and safety of secukinumab in Indian patients with moderate to severe pLaque psoriasis requiring systemic therapy (PSO-REAL Study) - PSO-REAL study
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2018
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms PSO-REAL
- Sponsors Novartis
- 11 Oct 2018 Status changed from recruiting to completed.
- 03 Apr 2017 Status changed from not yet recruiting to recruiting.
- 14 Feb 2017 New trial record